SG11201601488VA - Host cell modification with artificial endosymbionts - Google Patents

Host cell modification with artificial endosymbionts

Info

Publication number
SG11201601488VA
SG11201601488VA SG11201601488VA SG11201601488VA SG11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA
Authority
SG
Singapore
Prior art keywords
host cell
cell modification
artificial endosymbionts
endosymbionts
artificial
Prior art date
Application number
SG11201601488VA
Inventor
Caleb B Bell
Alexey Bazarov
Abdul Wareel
Joyce Barrozo
Original Assignee
Bell Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bell Biosystems Inc filed Critical Bell Biosystems Inc
Publication of SG11201601488VA publication Critical patent/SG11201601488VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
SG11201601488VA 2013-09-03 2014-09-03 Host cell modification with artificial endosymbionts SG11201601488VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361873308P 2013-09-03 2013-09-03
PCT/US2014/053954 WO2015034962A1 (en) 2013-09-03 2014-09-03 Host cell modification with artificial endosymbionts

Publications (1)

Publication Number Publication Date
SG11201601488VA true SG11201601488VA (en) 2016-03-30

Family

ID=52583776

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601488VA SG11201601488VA (en) 2013-09-03 2014-09-03 Host cell modification with artificial endosymbionts

Country Status (10)

Country Link
US (4) US9481869B2 (en)
EP (1) EP3041933A4 (en)
JP (1) JP2016528928A (en)
KR (1) KR20160048108A (en)
CN (1) CN106164268A (en)
AU (1) AU2014315321A1 (en)
CA (1) CA2923177A1 (en)
IL (1) IL244016A0 (en)
SG (1) SG11201601488VA (en)
WO (1) WO2015034962A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9023612B2 (en) 2012-01-13 2015-05-05 Bell Biosystems, Inc. Eukaryotic cells with artificial endosymbionts for multimodal detection
US10076579B2 (en) 2012-01-13 2018-09-18 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US8828681B2 (en) 2012-01-13 2014-09-09 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US8956873B2 (en) 2012-01-13 2015-02-17 Bell Biosystems, Inc. Host cells with artificial endosymbionts
WO2014145785A1 (en) 2013-03-15 2014-09-18 Bell Biosystems, Llc Host cells with artificial endosymbionts
KR20160048108A (en) 2013-09-03 2016-05-03 벨 바이오시스템즈, 인크. Host cell modification with artificial endosymbionts
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
KR20160119799A (en) * 2014-02-13 2016-10-14 벨 바이오시스템즈, 인크. Systems for making host cells with artificial endosymbionts
WO2016054298A1 (en) * 2014-10-01 2016-04-07 Bell Biosystems, Inc. Magnetogenetics
JP2020000167A (en) * 2018-06-29 2020-01-09 国立大学法人広島大学 Method for producing itaconic acid using psychrophile
CN110229762A (en) * 2019-03-04 2019-09-13 西北大学 One plant has the hydrogen-oxidizing bacterium of Plant growth promotion and its is separately cultured and applies

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385119A (en) 1980-03-27 1983-05-24 Biomagnetech Corp. Magnetic bacteria and products derived therefrom
US4677067A (en) 1984-06-22 1987-06-30 Bio-Magnetech Corporation Magnetotactic bacteria in clinical assay, immunoassay, and cell separation procedures and the like
JPS62275679A (en) 1986-05-23 1987-11-30 Tdk Corp Preparation of cell containing fine magnetic particle
US5843643A (en) 1992-02-21 1998-12-01 Ratner; Paul L. Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid
US6436694B1 (en) 1998-01-09 2002-08-20 Cubist Pharmaceuticals, Inc. Regulable gene expression in gram-positive bacteria
US6753171B2 (en) 1998-03-12 2004-06-22 Center For Advanced Science And Technology Incubation, Ltd. Site-specific cell perforation technique
US6004815A (en) 1998-08-13 1999-12-21 The Regents Of The University Of California Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
US8406498B2 (en) 1999-01-25 2013-03-26 Amnis Corporation Blood and cell analysis using an imaging flow cytometer
US20020012698A1 (en) 1999-09-01 2002-01-31 Edmund Bauerlein Magnetosomes, method for making and using
EP1281767A3 (en) 2001-07-31 2003-05-28 Aladar A. Szalay Light emitting microorganisms and cells for diagnosis and therapy of tumors
GB0121126D0 (en) 2001-08-31 2001-10-24 Univ Nottingham Systemic non-nodular endosymbiotic nitrogen fixation in plants
AU2003301322A1 (en) 2002-10-16 2004-05-04 Yoshiro Okami Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material
JP3934673B1 (en) 2003-06-18 2007-06-20 ジェネラックス・コーポレイション Modified recombinant vaccinia virus and other microorganisms, use thereof
US7390646B2 (en) 2003-09-17 2008-06-24 The Regents Of The University Of California Bacterial vectors and methods of use thereof
GB0329310D0 (en) 2003-12-18 2004-01-21 Univ Keele Method
EP1655370A1 (en) 2004-11-05 2006-05-10 Gesellschaft für Biotechnologische Forschung Bacterial vector
US20090311194A1 (en) 2005-04-29 2009-12-17 Emory University Methods and compositions for the production and use of magnetosomes
US20090325258A1 (en) 2005-06-03 2009-12-31 Tokyo University Of Agriculture And Technology Magnetic particle holding carrier and method for preparing the same
EP1919507A2 (en) 2005-08-04 2008-05-14 Thomas William Rademacher Nanoparticles comprising antibacterial ligands
US8906390B2 (en) 2006-03-24 2014-12-09 Gencia Corporation Synthetic lipid rafts and methods of use
US20070258886A1 (en) 2006-04-14 2007-11-08 Celsense Inc. Methods for assessing cell labeling
CA2655118C (en) 2006-06-08 2015-10-06 Multi-Magnetics Incorporated Magnetosome gene expression in eukaryotic cells
US8361437B2 (en) 2007-08-28 2013-01-29 University Of Florida Research Foundation, Inc. Multimodal nanoparticles for non-invasive bio-imaging
DE102008049771A1 (en) 2008-09-30 2010-04-08 Siemens Aktiengesellschaft Combined Magnetic Resonance Imaging and Guidance Device for Magnetic Particles
US20100135912A1 (en) 2008-12-02 2010-06-03 Gambhir Sanjiv S Magnetotactic bacteria mri positive contrast enhancement agent and methods of use
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
GB0905331D0 (en) 2009-03-27 2009-05-13 Avecia Biolog Ltd Expression process
FR2948125B1 (en) 2009-07-17 2011-08-26 Zoran Dermanovic METHODS FOR ESTABLISHING SYMBIOSES
US9359623B2 (en) 2009-07-24 2016-06-07 The Regents Of The University Of California Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms
RU2593331C2 (en) 2009-11-18 2016-08-10 Нанобактери Treating cancer and tumour, stimulated by release of heat generated by different chains of magnetosomes recovered from magneto-tactical bacteria and subjected to action of alternating magnetic field
US8617888B2 (en) 2010-07-23 2013-12-31 University Of Florida Research Foundation, Inc. Bacterial mediated delivery of nuclear protein into pluripotent and differentiated cells
US8828681B2 (en) * 2012-01-13 2014-09-09 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US8956873B2 (en) * 2012-01-13 2015-02-17 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US9023612B2 (en) 2012-01-13 2015-05-05 Bell Biosystems, Inc. Eukaryotic cells with artificial endosymbionts for multimodal detection
US9387264B2 (en) 2012-04-05 2016-07-12 Yeda Research And Development Co. Ltd. Reporter genes for magnetic resonance imaging and methods of use thereof
MX2015002917A (en) 2012-09-07 2015-06-03 Genentech Inc Methods and compositions for producing induced hepatocytes.
WO2014145785A1 (en) * 2013-03-15 2014-09-18 Bell Biosystems, Llc Host cells with artificial endosymbionts
KR20160048108A (en) 2013-09-03 2016-05-03 벨 바이오시스템즈, 인크. Host cell modification with artificial endosymbionts
KR20160119799A (en) * 2014-02-13 2016-10-14 벨 바이오시스템즈, 인크. Systems for making host cells with artificial endosymbionts

Also Published As

Publication number Publication date
US20170037378A1 (en) 2017-02-09
US9752129B2 (en) 2017-09-05
CA2923177A1 (en) 2015-03-12
US9481869B2 (en) 2016-11-01
CN106164268A (en) 2016-11-23
EP3041933A4 (en) 2017-04-26
AU2014315321A1 (en) 2016-03-03
US20190112581A1 (en) 2019-04-18
WO2015034962A1 (en) 2015-03-12
US10184114B2 (en) 2019-01-22
US20170362576A1 (en) 2017-12-21
US20150064787A1 (en) 2015-03-05
IL244016A0 (en) 2016-04-21
EP3041933A1 (en) 2016-07-13
KR20160048108A (en) 2016-05-03
WO2015034962A8 (en) 2016-04-21
JP2016528928A (en) 2016-09-23

Similar Documents

Publication Publication Date Title
HK1223554A1 (en) Cell
IL244016A0 (en) Host cell modification with artificial endosymbionts
AU356417S (en) Battery
EP3033769A4 (en) Memory cell with independently-sized elements
HK1200014A1 (en) Host cells with artificial endosymbionts
EP2945204A4 (en) Battery case
GB201303814D0 (en) Battery structure
HK1212578A1 (en) Implantable device with bridge
EP2988346A4 (en) Cell case
EP3067906A4 (en) Electrochemical device
GB201319087D0 (en) Artificial airway device
IL247044A0 (en) Systems for making host cells with artificial endosymbionts
GB201312332D0 (en) Cell locations
GB201310031D0 (en) Cell
EP2953200A4 (en) Battery
EP3038195A4 (en) Lithium cell
EP3018750A4 (en) Cell
GB201309576D0 (en) Nuclear battery
GB2510813B (en) Letter-plate with fluid-damped hinges
GB201312803D0 (en) Cell component
GB201320573D0 (en) T Cell
GB201317589D0 (en) Cell
AU2013903873A0 (en) Battery Reader
GB201317735D0 (en) Solar sphere
TWM477080U (en) Socket with storage function